| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.31B | — | +22.6% |
| Cost of Revenue | $1.62B | — | +40.1% |
| Gross Profit | $687.0M | — | -5.4% |
| R&D Expense | $316.0M | — | +11.7% |
| SG&A Expense | $179.0M | — | +37.7% |
| Operating Income | $176.0M | — | -39.5% |
| Pre-tax Income | $124.0M | +108.4% |
| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.44B | -2.6% | — |
| Accounts Receivable | $1.19B | +11.7% | — |
| Inventory | $1.91B | -8.3% | — |
| Current Assets | $4.98B | -2.0% | — |
| Total Assets | $12.75B | -1.8% | — |
| Current Liabilities | $1.52B |
| Line Item | 2025-10-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $488.0M | — | +472.5% |
| Capital Expenditures | $50.0M | — | -25.4% |
| Investing Cash Flow | -$15.0M | — | +21.1% |
| Financing Cash Flow | -$515.0M | — | -340.7% |
| Free Cash Flow | $438.0M | — | +321.2% |
| -53.6% |
| Income Tax | $12.0M | -92.6% | -78.6% |
| Net Income | $112.0M | — | -46.9% |
| EPS (Basic) | $0.77 | — | -47.3% |
| EPS (Diluted) | $0.75 | — | -48.6% |
| +6.2% |
| — |
| Long-term Debt | $1.35B | -26.9% | — |
| Total Liabilities | $3.37B | -10.6% | — |
| Stockholders' Equity | $9.38B | +1.8% | -22.6% |